RAS-TARGETING CANCER THERAPIES: PAST, PRESENT AND FUTURE

Date of Event:
2021-06-26
Time:
No
Organiser:

1. Hong Kong Society of Clinical Oncology

2. Amgen Inc.

Supporting Organisation:

The Society of Hospital Pharmacists of Hong Kong

Moderator:

TBC

Speaker:

TBC

Agenda:

TBC

We have come a long way in developing treatment for cancer.
Taking RAS as an example, it was one of the first family of oncogenes discovered in 1960s. Since then, the RAS signalling pathway has been studied extensively and many therapeutic targets have been uncovered.